stars 1 stars 2 stars 3

QuantumCyte is a technology platform company that developed an ‘in-situ lysis’ method for isolating complex regions of interest (ROIs) from FFPE tissue slides. Our product is an automated tissue dissection system that uses digital tissue maps to isolate ROIs that contain informative biomarkers for treatment decision support. Our system performs high-resolution and high-throughput tissue dissection relevant for clinical diagnostics (precision medicine) and large-scale biomarker studies (biopharma).

QuantumCyte, Inc. Questions

The QuantumCyte, Inc. annual revenue was $7.9 million in 2026.

John Butler is the CEO of QuantumCyte, Inc..

9 people are employed at QuantumCyte, Inc..

QuantumCyte, Inc. is based in Sunnyvale, California.

The NAICS codes for QuantumCyte, Inc. are [54, 54171, 5417, 541, 541713].

The SIC codes for QuantumCyte, Inc. are [87, 873].

Top QuantumCyte, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users